HB 1304

AN ACT relating to required labeling of certain products containing or

House Bill Hopper | Oliverson
Filed

Filed

Bill introduced by legislator

Committee

Hearing

Passed Cmte

Calendar

Passed

Sent

Enrolled

Governor

Signed

89th Regular Session

Jan 14, 2025 - Jun 2, 2025 • Session ended

Awaiting Committee Assignment

Bill filed, pending referral to House committee

← Back to Bills

Committee

Not yet assigned

Fiscal Note

Not available

What This Bill Does

This Texas bill requires clear labeling for food, medical, and cosmetic products that contain, are manufactured using, or derived from human fetal tissue obtained from abortions. Manufacturers, sellers, and distributors of these products in Texas must label them conspicuously according to rules established by the Texas Health and Human Services Commission by December 1, 2025. The law will apply to products sold, dispensed, or administered on or after January 1, 2026, affecting businesses in food, medical, and cosmetic industries that use such tissue in their products.

Subject Areas

Bill Text

relating to required labeling of certain products containing or
derived from aborted human fetal tissue.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.  Subchapter D, Chapter 431, Health and Safety
Code, is amended by adding Section 431.085 to read as follows:
Sec. 431.085.  LABELING REQUIRED FOR FETAL TISSUE FOOD
PRODUCT.  (a)  In this section:
(1)  "Fetal tissue food product" means a food or food
(A)  contains human fetal tissue;
(B)  is manufactured using human fetal tissue; or
(C)  is otherwise derived from research using
(2)  "Human fetal tissue" means tissue, cells,
including cells from fetal cell lines, or organs obtained or
originally derived from an aborted unborn child.
(b)  A person may not sell in this state a fetal tissue food
product unless the product is clearly and conspicuously labeled in
accordance with department rules.
(c)  The executive commissioner by rule shall prescribe the
form and contents of the label required by Subsection (b).
SECTION 2.  Subchapter E, Chapter 431, Health and Safety
Code, is amended by adding Section 431.118 to read as follows:
Sec. 431.118.  LABELING REQUIRED FOR FETAL TISSUE MEDICAL
PRODUCT.  (a)  In this section:
(1)  "Fetal tissue medical product" means a medication,
vaccine, or other medical product used in medical treatment that:
(A)  contains human fetal tissue;
(B)  is manufactured using human fetal tissue; or
(C)  is otherwise derived from research using
(2)  "Human fetal tissue" means tissue, cells,
including cells from fetal cell lines, or organs obtained or
originally derived from an aborted unborn child.
(b)  A person may not sell, dispense, or administer in this
state a fetal tissue medical product unless the product is clearly
and conspicuously labeled in accordance with department rules.
(c)  The executive commissioner by rule shall prescribe the
form and contents of the label required by Subsection (b).
SECTION 3.  Subchapter F, Chapter 431, Health and Safety
Code, is amended by adding Section 431.143 to read as follows:
Sec. 431.143.  LABELING REQUIRED FOR FETAL TISSUE COSMETIC
PRODUCT.  (a)  In this section:
(1)  "Fetal tissue cosmetic product" means a cosmetic
(A)  contains human fetal tissue;
(B)  is manufactured using human fetal tissue; or
(C)  is otherwise derived from research using
(2)  "Human fetal tissue" means tissue, cells,
including cells from fetal cell lines, or organs obtained or
originally derived from an aborted unborn child.
(b)  A person may not sell in this state a fetal tissue
cosmetic product unless the product is clearly and conspicuously
labeled in accordance with department rules.
(c)  The executive commissioner by rule shall prescribe the
form and contents of the label required by Subsection (b).
SECTION 4.  (a)  Not later than December 1, 2025, the
executive commissioner of the Health and Human Services Commission
shall adopt the form and content of the labels required under
Sections 431.085, 431.118, and 431.143, Health and Safety Code, as
(b)  Sections 431.085, 431.118, and 431.143, Health and
Safety Code, as added by this Act, apply only to a fetal tissue
product sold, dispensed, or administered on or after January 1,
SECTION 5.  This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution.  If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2025.

Bill History

filed

Bill filed: AN ACT relating to required labeling of certain products containing or